Literature DB >> 10215638

Combination of hypoxia/aglycemia compromises in vitro blood-brain barrier integrity.

T J Abbruscato1, T P Davis.   

Abstract

Increased cerebrovascular permeability is an important factor in the development of cerebral edema after stroke, implicating the blood-brain barrier (BBB) in the pathology of stroke. Present investigations modeled stroke at the level of the cerebral capillary endothelium by analyzing BBB permeability changes to the membrane-impermeant marker [14C]sucrose after hypoxia/aglycemia. Under hypoxia alone, long exposures (48 h) were necessary to result in a significant increase in permeability of bovine brain microvessel endothelial cells to [14C]sucrose. Hypoxia/aglycemia exposures resulted in a much shorter time (i.e., 1-3 h) required for a corresponding increase in permeability to [14C]sucrose. Statistically significant changes in basal permeability were observed between 3 and 6 h of hypoxia/aglycemia; however, 6 h of aglycemia alone had no significant effect on BBB permeability. Both rat astroglioma (C6) cells and C6 conditioned medium showed no improvements in barrier function measured by transendothelial cell resistance or permeability to [14C]sucrose. Changes in endothelial cell calcium flux may be responsible for the permeability change observed after both 48 h of hypoxia and 6 h of hypoxia/aglycemia because nifedipine (10 and 100 nM) and SKF 96365 (100 nM) decreased the permeability change. Immunocytochemical studies also revealed a change in the distribution of endothelial cell F-actin. This study provides evidence that the BBB is sensitive to short exposures of hypoxia/aglycemia and that changes in endothelial cell calcium flux may be responsible for structural and functional variations in the BBB during ischemic stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215638

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Involvement of glial cells in cyclosporine-increased permeability of brain endothelial cells.

Authors:  S Dohgu; Y Kataoka; H Ikesue; M Naito; T Tsuruo; R Oishi; Y Sawada
Journal:  Cell Mol Neurobiol       Date:  2000-12       Impact factor: 5.046

2.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 3.  In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use.

Authors:  Hans C Helms; N Joan Abbott; Malgorzata Burek; Romeo Cecchelli; Pierre-Olivier Couraud; Maria A Deli; Carola Förster; Hans J Galla; Ignacio A Romero; Eric V Shusta; Matthew J Stebbins; Elodie Vandenhaute; Babette Weksler; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2016-02-11       Impact factor: 6.200

Review 4.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells.

Authors:  Rachel C Brown; Andrew P Morris; Roger G O'Neil
Journal:  Brain Res       Date:  2006-12-12       Impact factor: 3.252

6.  Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells.

Authors:  István A Krizbai; Hannelore Bauer; Nicolaus Bresgen; Peter M Eckl; Attila Farkas; Erzsébet Szatmári; Andreas Traweger; Katarzyna Wejksza; Hans-Christian Bauer
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

7.  Role of astrocytic leptin receptor subtypes on leptin permeation across hCMEC/D3 human brain endothelial cells.

Authors:  Hung Hsuchou; Abba J Kastin; Hong Tu; N Joan Abbott; Pierre-Olivier Couraud; Weihong Pan
Journal:  J Neurochem       Date:  2010-10-26       Impact factor: 5.372

Review 8.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 9.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

10.  A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation.

Authors:  Sharanya Vemula; Karen E Roder; Tianzhi Yang; G Jayarama Bhat; Thomas J Thekkumkara; Thomas J Abbruscato
Journal:  J Pharmacol Exp Ther       Date:  2008-11-03       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.